# Catherine Green

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/catherine-green/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,001 |
| Field | DNA Repair Mechanisms |
| h-index | 56 |
| i10-index | 97 |
| Last Known Institution | Oxford BioMedica (United Kingdom) |
| OpenAlex ID | https://openalex.org/A5047085385 |
| ORCID iD | https://orcid.org/0000-0002-7068-7106 |
| Works | 177 |

## Researcher papers

- [Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK](https://scholariq.org/papers/safety-and-efficacy-of-the-chadox1-ncov-19-vaccine-azd1222-against-sars-cov-2-an/)
- [Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial](https://scholariq.org/papers/safety-and-immunogenicity-of-the-chadox1-ncov-19-vaccine-against-sars-cov-2-a/)
- [Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials](https://scholariq.org/papers/single-dose-administration-and-the-influence-of-the-timing-of-the-booster-dose/)
- [T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial](https://scholariq.org/papers/t-cell-and-antibody-responses-induced-by-a-single-dose-of-chadox1-ncov-19/)
- [Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses](https://scholariq.org/papers/phase-1-2-trial-of-sars-cov-2-vaccine-chadox1-ncov-19-with-a-booster-dose/)
- [Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine](https://scholariq.org/papers/native-like-sars-cov-2-spike-glycoprotein-expressed-by-chadox1-ncov-19-azd1222/)

## Researcher topics

- [DNA Repair Mechanisms](https://scholariq.org/topics/dna-repair-mechanisms/)
- [Genomics and Chromatin Dynamics](https://scholariq.org/topics/genomics-and-chromatin-dynamics/)
- [Glaucoma and retinal disorders](https://scholariq.org/topics/glaucoma-and-retinal-disorders/)
- [CRISPR and Genetic Engineering](https://scholariq.org/topics/crispr-and-genetic-engineering/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)

## Researcher university

- [Oxford BioMedica (United Kingdom)](https://scholariq.org/institutions/oxford-biomedica-united-kingdom/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.